CROSSROADS STRATEGIES, LLC

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $50,000.00 income · posted Jul 19, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to CMMI Drug Pricing Demonstration Programs (GLOBE and GUARD Models).

Health Issues

Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Section 301 tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.